These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 379689)

  • 1. Meige disease: striatal dopaminergic preponderance.
    Tolosa ES; Lai C
    Neurology; 1979 Aug; 29(8):1126-30. PubMed ID: 379689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia.
    Stahl SM; Yesavage JA; Berger PA
    J Clin Psychiatry; 1982 Nov; 43(11):445-6. PubMed ID: 7174619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of blepharospasm-oromandibular dystonia syndrome.
    Casey DE
    Neurology; 1980 Jul; 30(7 Pt 1):690-5. PubMed ID: 7190236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meige disease: acute and chronic cholinergic effects.
    Tanner CM; Glantz RH; Klawans HL
    Neurology; 1982 Jul; 32(7):783-5. PubMed ID: 7201118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
    Mauriello JA; Coniaris H; Haupt EJ
    Ophthalmology; 1987 Aug; 94(8):976-9. PubMed ID: 3658375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meige syndrome (blepharospasm-oromandibular dystonia) after long-term neuroleptic therapy.
    Weiner WJ; Nausieda PA; Glantz RH
    Neurology; 1981 Dec; 31(12):1555-6. PubMed ID: 6118844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meige's syndrome: clinical, pharmacological and radiological observations.
    Chopra JS; Radhakrishnan K; Sridharan R
    Clin Neurol Neurosurg; 1981; 83(3):145-52. PubMed ID: 6274556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients.
    Jankovic J; Ford J
    Ann Neurol; 1983 Apr; 13(4):402-11. PubMed ID: 6838174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
    Jankovic J
    Adv Neurol; 1988; 49():103-16. PubMed ID: 3278535
    [No Abstract]   [Full Text] [Related]  

  • 10. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects.
    Tolosa E; Martí MJ
    Adv Neurol; 1988; 49():73-84. PubMed ID: 3278555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of blepharospasm with levodopa.
    Chakravorty NK
    Postgrad Med J; 1974 Aug; 50(586):521-23. PubMed ID: 4464520
    [No Abstract]   [Full Text] [Related]  

  • 12. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
    Napolitano A; Bonuccelli U; Rossi B
    Eur Neurol; 1997; 38(2):119-22. PubMed ID: 9286635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trials in Meige syndrome.
    Gollomp SM; Fahn S; Burke RE; Reches A; Ilson J
    Adv Neurol; 1983; 37():207-13. PubMed ID: 6344589
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the anti-dyskinesia effect of apomorphine in man.
    Tolosa ES
    Neurol Neurocir Psiquiatr; 1976; 17(4):223-9. PubMed ID: 138800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters.
    Löscher W; Fredow G
    Eur J Pharmacol; 1992 Mar; 213(1):31-9. PubMed ID: 1323471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
    Mauriello JA
    Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
    Rupniak NM; Tye SJ; Steventon MJ; Boyce S; Iversen SD
    Mov Disord; 1990; 5(4):314-8. PubMed ID: 2259355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating and preventing levodopa-induced dyskinesias: current and future strategies.
    Durif F
    Drugs Aging; 1999 May; 14(5):337-45. PubMed ID: 10408734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.